MapLight Therapeutics, Inc. SEC filings MPLT
MapLight Therapeutics, Inc. has 209 filings in SEC EDGAR's recent list, going back to Mar 8, 2019. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (material agreement, results of operations, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Sep 23, 2026 | — |
| 424B3 | Prospectus | Sep 23, 2026 | — |
| S-1/A | Amended registration statement | Sep 18, 2026 | — |
| S-1 | Registration statement | Sep 9, 2026 | — |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 27, 2026 | Jul 27, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2026 | Jun 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 22, 2026 | Jun 22, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 18, 2026 | Jun 18, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 29, 2026 | Apr 23, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Jun 23, 2026 |
| S-8 | Employee stock plan registration | Mar 26, 2026 | — |
| 10-K | Annual report | Mar 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 26, 2026 | Mar 26, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 9, 2026 | Jan 9, 2026 |
| 10-Q | Quarterly report | Dec 4, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Dec 4, 2025 | Dec 4, 2025 |
| 8-K |
Current report
Unregistered share sale, Bylaw or fiscal year change, Other events
|
Oct 29, 2025 | Oct 26, 2025 |
| 424B3 | Prospectus | Oct 27, 2025 | — |
| S-8 | Employee stock plan registration | Oct 27, 2025 | — |
| FWP | Free writing prospectus | Oct 27, 2025 | — |
| CERT | Filing | Oct 24, 2025 | — |
| 8-A12B | Filing | Oct 24, 2025 | — |
| FWP | Free writing prospectus | Oct 6, 2025 | — |
| S-1/A | Amended registration statement | Oct 6, 2025 | — |
| S-1 | Registration statement | Sep 19, 2025 | — |
| DRSLTR | Filing | Aug 22, 2025 | — |
| DRS/A | Filing | Aug 22, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 12, 2025 | — |
| DRS/A | Filing | Jul 30, 2025 | — |
| D | Filing | Jul 28, 2025 | — |
| DRSLTR | Filing | May 10, 2024 | — |
| DRS/A | Filing | May 10, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 24, 2024 | — |
| DRSLTR | Filing | Apr 12, 2024 | — |
| DRS/A | Filing | Apr 12, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 4, 2024 | — |
| DRS | Filing | Mar 8, 2024 | — |
| D/A | Filing | Nov 3, 2023 | — |
| D | Filing | Jul 19, 2023 | — |
| D | Filing | Nov 10, 2022 | — |
| D | Filing | Mar 10, 2021 | — |
| D | Filing | Sep 4, 2019 | — |
| D/A | Filing | Mar 22, 2019 | — |
| D | Filing | Mar 8, 2019 | — |
Showing 50 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MPLT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Redwood City, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1770069
- Former names
- Alvarado Therapeutics, Inc. (until Mar 22, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.